Market Value445,291,323
Total Holdings71
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MORF / Morphic Holding, Inc.
RLMD / Relmada Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
MGNX / MacroGenics, Inc.
EVGN / Evogene Ltd.
JSPR / Jasper Therapeutics, Inc.
MERSANA THERAPEUTICS INC / CALL Call (59045L906)
ENGN / enGene Holdings Inc.
SLNO / Soleno Therapeutics, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
VYNE / VYNE Therapeutics Inc.
ADCT / ADC Therapeutics SA
BDTX / Black Diamond Therapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
ALNY / Alnylam Pharmaceuticals, Inc.
ERAS / Erasca, Inc.
GUTS / Fractyl Health, Inc.
COGT / Cogent Biosciences, Inc.
OLMA / Olema Pharmaceuticals, Inc.
PSTX / Poseida Therapeutics, Inc.
CATX / Perspective Therapeutics, Inc.
INSM / Insmed Incorporated
SRPT / Sarepta Therapeutics, Inc.
ZVRA / Zevra Therapeutics, Inc.
EVGN / Evogene Ltd.
PRAX / Praxis Precision Medicines, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
BIOA / BioAge Labs, Inc.
PCVX / Vaxcyte, Inc.
ETNB / 89bio, Inc.
IRON / Disc Medicine, Inc.
BDSX / Biodesix, Inc.
UNCY / Unicycive Therapeutics, Inc.
BHVN / Biohaven Ltd.
GERN / Geron Corporation
TELA / TELA Bio, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
SLDB / Solid Biosciences Inc.
CCCC / C4 Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
MRSN / Mersana Therapeutics, Inc. Call
CERS / Cerus Corporation
PTGX / Protagonist Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
ZURA / Zura Bio Limited
STOK / Stoke Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RNA / Avidity Biosciences, Inc.
URGN / UroGen Pharma Ltd.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
VCYT / Veracyte, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CGEN / Compugen Ltd.
SNDX / Syndax Pharmaceuticals, Inc.
MRUS / Merus N.V.
ORIC / ORIC Pharmaceuticals, Inc.
CLDX / Celldex Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
TIL / Instil Bio, Inc.
RLAY / Relay Therapeutics, Inc.
INSM / Insmed Incorporated Call
KOD / Kodiak Sciences Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
TRVI / Trevi Therapeutics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
XNCR / Xencor, Inc.
KPTI / Karyopharm Therapeutics Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ITCI / Intra-Cellular Therapies, Inc.
VXRT / Vaxart, Inc.
ALXO / ALX Oncology Holdings Inc. Put
APLT / Applied Therapeutics, Inc.
MODD / Modular Medical, Inc.
ELUT / Elutia Inc.
HLXB / Helix Acquisition Corp. II
CCCC / C4 Therapeutics, Inc. Call
NUVL / Nuvalent, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
MTEM / Molecular Templates, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc. Call
EYPT / EyePoint Pharmaceuticals, Inc.